vTv Therapeutics CEO Stephen Holcombe's 2020 pay jumps 68% to $1.4M

vTv Therapeutics reports 2020 executive compensation

By ExecPay News

Published: March 18, 2021

vTv Therapeutics reported fiscal year 2020 executive compensation information on March 18, 2021.
In 2020, three executives at vTv Therapeutics received on average a compensation package of $978K, a 87% increase compared to previous year.
Average pay of disclosed executives at vTv Therapeutics
Stephen L. Holcombe, Chief Executive Officer, received $1.4M in total, which increased by 68% compared to 2019. 51% of Holcombe's compensation, or $716K, was in option awards. Holcombe also received $225K in non-equity incentive plan, $450K in salary, as well as $9.7K in other compensation.
Rudy C. Howard, Chief Financial Officer, received a compensation package of $935K, which increased by 58% compared to previous year. 48% of the compensation package, or $448K, was in option awards.
Robin E. Abrams, Chairperson of the Board of Directors, earned $599K in 2020, a 52% increase compared to previous year.

Related executives

Stephen Holcombe

vTv Therapeutics

Chief Executive Officer

Rudy Howard

vTv Therapeutics

Chief Financial Officer

Robin Abrams

vTv Therapeutics

Chairperson of the Board of Directors

You may also like

Source: SEC filing on March 18, 2021.